Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Deferred Taxes (2020 - 2021)

Journey Medical (DERM) has disclosed Deferred Taxes for 2 consecutive years, with $8.3 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Deferred Taxes rose 2281.27% year-over-year to $8.3 million, compared with a TTM value of $1.6 million through Dec 2021, changed N/A, and an annual FY2021 reading of $1.6 million, up 567.46% over the prior year.
  • Deferred Taxes was $8.3 million for Q4 2021 at Journey Medical, up from -$3.3 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $8.3 million in Q4 2021 and bottomed at -$3.5 million in Q2 2021.